129 related articles for article (PubMed ID: 11545432)
1. Intermittent blurred vision and trichomegaly due to latanoprost.
Woo TL; Francis IC
Clin Exp Ophthalmol; 2001 Aug; 29(4):272-3. PubMed ID: 11545432
[No Abstract] [Full Text] [Related]
2. Latanoprost and hyperpigmentation of eyelashes.
Wand M
Arch Ophthalmol; 1997 Sep; 115(9):1206-8. PubMed ID: 9298071
[No Abstract] [Full Text] [Related]
3. Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost.
Özyurt S; Çetinkaya GS
Actas Dermosifiliogr; 2015; 106(1):74-5. PubMed ID: 25065768
[No Abstract] [Full Text] [Related]
4. Lash ptosis caused by latanoprost.
Casson RJ; Selva D
Am J Ophthalmol; 2005 May; 139(5):932-3. PubMed ID: 15860312
[TBL] [Abstract][Full Text] [Related]
5. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost.
Chiba T; Kashiwagi K; Ishijima K; Furuichi M; Kogure S; Abe K; Chiba N; Tsukahara S
Jpn J Ophthalmol; 2004; 48(2):141-7. PubMed ID: 15060793
[TBL] [Abstract][Full Text] [Related]
7. Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study.
Stecchi G; Saccucci S; Molinari S; De Gregorio F
Acta Ophthalmol Scand Suppl; 2002; 236():56-7. PubMed ID: 12390146
[No Abstract] [Full Text] [Related]
8. Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal.
Waheed K; Laganowski H
Eye (Lond); 2001 Jun; 15(Pt 3):347-9. PubMed ID: 11450742
[No Abstract] [Full Text] [Related]
9. Prostaglandin-induced hair growth.
Johnstone MA; Albert DM
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S185-202. PubMed ID: 12204716
[TBL] [Abstract][Full Text] [Related]
10. Poliosis associated with treatment of fungal endophthalmitis.
Watson AS; Giledi O; Daya SM
Orbit; 2004 Dec; 23(4):241-4. PubMed ID: 15590526
[TBL] [Abstract][Full Text] [Related]
11. Eyelid hypertrichosis associated with latanoprost is reversible.
O'Toole L; Cahill M; O'Brien C
Eur J Ophthalmol; 2001; 11(4):377-9. PubMed ID: 11820311
[TBL] [Abstract][Full Text] [Related]
12. Topical prostaglandin F(2alpha) analog induced poliosis.
Chen CS; Wells J; Craig JE
Am J Ophthalmol; 2004 May; 137(5):965-6. PubMed ID: 15126178
[TBL] [Abstract][Full Text] [Related]
13. [Increased myopia and metaporphosia in a 59-year old patient. Serous retinal detachment of the posterior pol after latanoprost administration].
Sauer S; Coracas A; Eckhardt C
Ophthalmologe; 2003 Jan; 100(1):62-3. PubMed ID: 12608405
[No Abstract] [Full Text] [Related]
14. Serous retinal detachment in the macula related to latanoprost use.
Ozkan B; Karabaş VL; Yüksel N; Cağlar Y
Int Ophthalmol; 2008 Oct; 28(5):363-5. PubMed ID: 17805489
[TBL] [Abstract][Full Text] [Related]
15. Eyelash hypertrichosis in a patient treated with topical latanoprost.
Strober BE; Potash S; Grossman ME
Cutis; 2001 Feb; 67(2):109-10. PubMed ID: 11236218
[TBL] [Abstract][Full Text] [Related]
16. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost.
Johnstone MA
Am J Ophthalmol; 1997 Oct; 124(4):544-7. PubMed ID: 9323945
[TBL] [Abstract][Full Text] [Related]
17. The comparison of eyelash lengthening effect of latanoprost therapy in adults and children.
Elgin U; Batman A; Berker N; Ilhan B
Eur J Ophthalmol; 2006; 16(2):247-50. PubMed ID: 16703542
[TBL] [Abstract][Full Text] [Related]
18. Transient monocular visual loss following administration of topical latanoprost: a case report.
Luu ST; Lee AW; Chen CS
Can J Ophthalmol; 2009 Dec; 44(6):715. PubMed ID: 20029498
[No Abstract] [Full Text] [Related]
19. Central serous chorioretinopathy associated with topical latanoprost therapy.
Artunay O; Senel A; Sengul A; Rasier R; Bahcecioglu H
Ocul Immunol Inflamm; 2011 Dec; 19(6):453-5. PubMed ID: 22106918
[TBL] [Abstract][Full Text] [Related]
20. Darkening of eyelashes in a patient treated with latanoprost.
Reynolds A; Murray PI; Colloby PS
Eye (Lond); 1998; 12 ( Pt 4)():741-3. PubMed ID: 9850277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
